Distinct Serum Extracellular Vesicle Proteomic Profiles Characterize Hepatic Steatosis in Women After Menopause - Top-Institutions - MDSpire

Distinct Serum Extracellular Vesicle Proteomic Profiles Characterize Hepatic Steatosis in Women After Menopause

  • By

  • Patrick Pirrotte

  • Brooke Lovell

  • Siobán D. Harlow

  • Carrie A. Karvonen-Gutierrez

  • Michelle M. Hood

  • Ignazio S. Piras

  • Xiumei Wu

  • Melissa N. Martinez

  • Ritin Sharma

  • Krystine Garcia-Mansfield

  • Maya Willey

  • Johanna K. DiStefano

  • December 7, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Endocrinology
    • Proteomics

  • #2

    University of California, San Diego (UCSD) School of Medicine
    University of California, San Diego (UCSD) School of Medicine

    San Diego, CA

    Key Differentiators

    • Hepatology
    • Metabolism
    • Women's Health

  • #3

    Harvard Medical School / Massachusetts General Hospital
    Harvard Medical School / Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Hepatology
    • Endocrinology
    • Proteomics

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Hepatology
    • Metabolic Disease
    • Women's Health

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Hepatology
    • Endocrinology
    • Proteomics

Original Source(s)

Distinct Serum Extracellular Vesicle Proteomic Profiles Characterize Hepatic Steatosis in Women After Menopause

  • by Patrick Pirrotte, Brooke Lovell, Siobán D. Harlow, Carrie A. Karvonen-Gutierrez, Michelle M. Hood, Ignazio S. Piras, Xiumei Wu, Melissa N. Martinez, Ritin Sharma, Krystine Garcia-Mansfield, Maya Willey, Johanna K. DiStefano

  • December 7, 2025

Related Content

Heart Failure with Preserved Ejection Fraction Viewed as a Systemic Inflammatory-Metabolic Condition: Insights from the Cardio-Hepato-Pancreatic Axis

Case Report: Hemophagocytic lymphohistiocytosis masquerading as drug-induced liver injury: successful treatment with low-dose ruxolitinib and glucocorticoids

Editorial: Digital technologies in hepatology: diagnosis, treatment, and epidemiological insights